The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet is: 00173/5006.
collodion, salicylic acid, lactic acid
Keep this leaflet. You may need to read it again. Ask your doctor or pharmacist if you need more information or advice.
1. What Salactol is and what it is used for
2. Before you use Salactol
3. How to use Salactol
4. Possible side effects
5. How to store Salactol
6. Further information
Do not use Salactol if you are allergic (hypersensitive) to salicylic acid, lactic acid or any of the other ingredients of Salactol listed in Section 6.
Take special care when using this product:
This product is not known to affect, or to be affected by any other medicines.
This product can be used during pregnancy and while breast feeding. The ingredients have been in widespread use in this and similar preparations for many years, without reports of problems. However, safety trials have not been conducted.
Using this product is not known to affect your ability to drive or use machinery.
Use it only on warts, verrucas, corns and calluses on sites for which it is recommended.
Follow these steps once every day, usually in the evening. Carry on using the product in this way until the wart, verruca, corn or callus disappears:
A. Soak the affected area in warm water for 2 to 3 minutes.
B. Dry the area thoroughly, using your own towel if you have a wart or verruca (this will help stop the infection spreading to other people).
C. Gently rub away any loose, hard skin from the surface of the wart, verruca, corn or callus with an emery board or a piece of pumice stone:
D. Unscrew the cap of the bottle and, using the applicator attached to the inside of the cap, carefully apply a few drops of the paint to the top of the wart, verruca, corn or callus only:
E. If the treated area is on the sole of the foot, cover it with an adhesive plaster to help prevent the virus from spreading. Elsewhere, treated areas need not be covered.
F. Always replace the cap of the bottle tightly after use.
G. Repeat steps A to F every evening, after removing any plaster from the previous day.
H. The length of treatment will vary depending on the size and resistance of the wart, verruca, corn or callus:
If Salactol accidentally gets on to normal skin, wipe it off straight away with a tissue, and, if necessary, wash the area.
If Salactol accidentally gets into the eye or is swallowed, go to a hospital Accident & Emergency department straight away.
If you inhale a lot of the vapour from the product it may make you feel light-headed. If this happens, get plenty of fresh air.
Do not worry if you occasionally forget to use this product, just carry on using it when you remember.
If you have any further questions on the use of this product, ask your doctor, nurse or pharmacist.
Like all medicines, Salactol can cause side effects although not everybody gets them:
If any of the side effects get serious, or if you notice any other side effect not mentioned in this leaflet, please tell your doctor or pharmacist.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see details below). By reporting side effects you can help provide more information on the safety of this medicine.
The active ingredients are salicylic acid (16.7% w/w) and lactic acid (16.7% w/w).
The other ingredients are pyroxylin, colophony, castor oil, industrial methylated spirit and ether.
This amber glass bottle contains 10 ml of collodian wart paint. The paint is colourless or pale yellow/brown. The bottle cap incorporates a specially designed applicator spatula.
This leaflet was last revised in January 2021.
To listen to or request a copy of this leaflet in Braille, large print or audio, please call free of charge: 0800 198 5000 (UK only).
Please be ready to give the following information: Salactol, 00173/5006
This is a service provided by the Royal National Institute of Blind People (RNIB).